New Advances and Opportunities for Improvement in HR+/HER2- Early Breast Cancer
Вставка
- Опубліковано 1 лют 2022
- Featured Expert, Sara M. Tolaney, MD, MPH, discusses breast cancer in this CME/MOC/CC/NCPD/CPE activity titled “New Advances and Opportunities for Improvement in HR+/HER2- Early Breast Cancer: Practical Strategies for Optimal Clinical Integration of Adjuvant CDK4 and 6 Inhibitor Therapy.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/AGM865. CME/MOC/CC/NCPD/CPE credit will be available until December 27, 2022.
